Melbourne biotech Cartherics raises $15m for ovarian cancer stem cell trial
The funds will also advance Cartherics to target stem cell therapy programs for pancreatic, gastric, liver, kidney, and prostate cancers.
The funds will also advance Cartherics to target stem cell therapy programs for pancreatic, gastric, liver, kidney, and prostate cancers.
Out of office, the former president has transformed his fortune, converting a real-estate empire into a political profit machine.
When being a billionaire just isn’t enough.
Ideally, which launched in 2023 to transform marketing and campaign management with real-time consumer insights, has raised $5.5 million to fuel its US expansion.
Qatar Airways has agreed to acquire a 25% stake in Virgin Australia, positioning the Australian airline to re-enter long-haul international routes. The deal awaits regulatory approval from the Foreign Investment Review Board.
Fidelity has repeatedly cut the value of its stake in the social media firm since Musk’s acquisition.
As data mining firm Palantir’s shares continue to climb, Thiel is cashing out. He’s not the only Palantir insider doing so.
Coinbase’s Brian Armstrong created one of crypto’s central players, a fee-gushing monster that holds more than a tenth of all the Bitcoin ever minted. But now, in the cause of “decentralization,” he’s pursuing a new path.
The bitcoin price has more than doubled over the last year, pushed higher by the world’s largest asset manager BlackRock’s embrace of crypto.
Walton overtook Meyers as the world’s richest woman early this month, the first time she secured the title since May 2022.